Skip to main content
. 2021 Jun 25;21:127. doi: 10.1186/s12902-021-00798-3

Fig. 1.

Fig. 1

The number of available new antidiabetic active substances in use for each country within the study period. Values in brackets indicate the total number of new active substances. Asterisks indicate countries with only retail sales data available